Search the Newsreel

Palisade Bio CEO, CFO Finley sells $303k in stock

John David Finley, CEO and CFO of Palisade Bio (NASDAQ:PALI), sold 146,798 shares for approximately $303,343 to cover tax obligations following the vesting of restricted stock units. This transaction occurred after a significant 184% return over the past year, though InvestingPro data suggests the …

Janus Henderson Group PLC Has $4.56 Million Position in Fair Isaac Corporation $FICO

Janus Henderson Group PLC significantly reduced its stake in Fair Isaac Corporation (NYSE:FICO) by 93.3% in the first quarter, selling nearly 60,000 shares but still retaining 4,275 shares valued at $4.56 million. Despite this large sale, other institutional investors have recently increased their positions …

Visaka Industries Q1FY27 net profit falls 4.5% as EBITDA surges 79%

Paisalo Digital reschedules FCCB committee meeting to August 12

Visaka Ind Standalone June 2026 Net Sales at Rs 588.85 crore, up 16.56% Y-o-Y

LISATA THERAPEUTICS, INC. 2026: Revenue $0 EPS ($0.32) — 10-Q Summary

Lisata Therapeutics, Inc. reported a Q2 2026 revenue of $0 and a diluted loss per share of ($0.32), with net loss narrowing to ($2.93M). The company is pursuing strategic alternatives due to near-term funding uncertainty, including a significant workforce reduction and a lawsuit following …

TriSalus Life Sciences Inc (TLSI) (Q2 2026) Earnings Call Highlights: New CMS G-code Expands ...

TriSalus Life Sciences Inc (TLSI) announced a new CMS G-code for TriNav reimbursement in office-based labs, significantly expanding market access and supporting full-year 2026 revenue guidance of $54 million to $57 million. While gross margin improved to 86.8%, Q2 revenue growth was modest at …

IDN Q2'26 Earnings: revenue estimate is 5.67M USD

Intellicheck, Inc. (IDN) is projected to announce its Q2'26 earnings on August 13th, after market close, with an expected revenue of $5.67 million and an EPS of $0.03. This report provides a detailed look at past revenue and EPS performance, including reported figures and …

Kaisa Health Plans Biotech-Focused Name Change After Acquisition

Earnings call transcript: TriSalus tops Q2 revenue forecast, stock slips after hours

TriSalus Life Sciences reported Q2 revenue of $11.4 million, surpassing forecasts, driven by increased adoption of its TriNav system. Despite the revenue beat, the stock slipped after hours due to a wider adjusted EBITDA loss and higher sales and marketing expenses. The company reiterated …

TriSalus Life Sciences, Inc. 2026: Revenue $11.41M, EPS ($0.16) — 10-Q Summary

TriSalus Life Sciences, Inc. (TLSI) reported its 2026 quarterly results, showing revenue of $11.41M, which was nearly flat year-over-year, and a net loss of ($9.19M), resulting in a diluted loss per share of ($0.16). The company highlighted stable revenue, improved gross margin, continued commercial …

CompoSecure Ord Shs Class A (GPGI) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for CompoSecure Ord Shs Class A (GPGI), detailing analyst ratings, target prices, and future EPS and revenue growth estimates. Based on one analyst, the stock holds a "Hold" rating with a target price of 25.000 USD, representing a …

CMRY's first-half net profit rises 17.88% to IDR 1.17 trillion

Fair Isaac Corporation $FICO Shares Acquired by Bank of America Corp DE

Bank of America Corp DE increased its stake in Fair Isaac Corporation (FICO) by 5.7% in the first quarter, now owning 133,448 shares worth approximately $142.5 million. Institutional investors hold a significant 85.75% of FICO's outstanding shares. Despite some recent price target reductions, analysts …

Palisade Bio Inc (PALI) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Palisade Bio Inc (PALI), highlighting its current earnings forecast score of 8.80 and an average price target of $8.00 based on 10 analyst ratings. Most analysts recommend a "Buy" for PALI, with expected EPS for the next …

Visaka Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

Inside TriSalus Life Sciences (NASDAQ: TLSI) Q2 2026 performance

Paisalo Digital Q1FY27 net profit rises 30% to ₹613 crore on AUM growth

Grupo Televisa, S.A.B. Sponsored ADR Revenue Breakdown – LS:888781

Grupo Televisa, S.A.B. Sponsored ADR (LS:888781) generated 2.88 billion EUR in revenue last year, with its Telecom segment being the highest contributor at 2.61 billion EUR. Mexico was the largest regional contributor, accounting for 2.56 billion EUR last year. The article provides a breakdown …

Lisata Therapeutics Announces Major Workforce Reduction and Retrenchment

Lisata Therapeutics has announced a significant workforce reduction of approximately 72%, aiming to cut operating expenses and explore strategic options. This move, approved on August 3, 2026, is expected to incur $1.2 million in severance costs. Concurrently, the company filed a lawsuit against Kuva …

Grupo Televisa Renews Market Maker Agreement for Mexican Shares

Grupo Televisa, S.A.B. has renewed its market maker agreement with Santander Casa de Bolsa for its shares traded on the Mexican Stock Exchange under the ticker TLEVISA CPO. This agreement, valid until August 8, 2027, aims to boost liquidity and orderly trading for its …

FICO Partnership Will Bring Credit Lessons to Students and Families

FICO is partnering with Seeds of Fortune Inc. and Marsai's Way Foundation to launch the FICO Financial Empowerment Fellowship. This initiative will train college students as peer ambassadors in credit education and financial wellness, offering ten $1,500 scholarships. The program aims to expand financial …

FICO Joins Marsai Martin's Foundation and Seeds of Fortune Inc. to Expand National Financial Empowerment Initiative for Families and College Students

Seeds of Fortune Inc. Partners with FICO to Launch FICO Financial Empowerment Fellowship NEW YORK, Aug. 5, 2026 /PRNewswire/ -- Seeds of Fortune Inc. and Marsai's Way Foundation are deepening their partnership to advance financial empowerment, building on a successful inaugural year that reached …

Paisalo Digital Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

Amerisafe (AMSF) EVP converts 4,257 RSUs, withholds 1,846 common shares

Amerisafe (AMSF) EVP Raymond F. Wise Jr. converted 4,257 restricted stock units (RSUs) into common shares on August 1, 2026. Concurrently, 1,846 common shares were withheld at $29.04 per share to cover tax obligations. Following these transactions, Wise holds 9,878 RSUs from an original …

Hisar Metal Industries completes dispatch of 36th AGM notice

Fair Isaac Corporation $FICO Shares Sold by Pacer Advisors Inc.

Pacer Advisors Inc. significantly reduced its stake in Fair Isaac Corporation (NYSE:FICO) by 94.7% in the first quarter, selling over 239,000 shares. Despite this, institutional investors still hold a large portion of the company's stock, and analysts maintain a "Moderate Buy" rating with a …

Earnings To Watch: TriSalus Life Sciences Inc (TLSI) Q2 2026 -- GF Value Sees 20% Upside

Paisalo Digital consolidated net profit rises 29.98% in the June 2026 quarter

TV|Grupo Televisa SAB|Price:2.835|Chg%:+0.095

Sei Investments Co. Has $5.27 Million Stock Position in Artisan Partners Asset Management Inc. $APAM

Does Stronger Earnings And A Higher Dividend Payout Change The Bull Case For Artisan Partners (APAM)?

Artisan Partners Asset Management (APAM) reported stronger second-quarter and first-half 2026 earnings, with increased revenue and net income, leading to a higher quarterly dividend of US$0.80 per share. While these results bolster its near-term investment narrative, the article questions whether earnings and cash generation …

Calisa Acquisition Corp (NASDAQ: ALIS) agrees to $8M share sale for Goodvision deal

5 Revealing Analyst Questions From Fair Isaac Corporation’s Q2 Earnings Call

Fair Isaac Corporation (FICO) reported Q2 results that missed revenue expectations but beat on adjusted EPS, leading to a negative market reaction. Despite this, management raised full-year revenue guidance, citing strong performance in its Scores segment and the rollout of FICO Score 10T. Analyst …

Lisata Therapeutics sues Kuva Labs, cuts 72% of workforce

Lisata Therapeutics has filed a lawsuit against Kuva Labs Inc. and its subsidiary in Delaware, seeking damages and a $2 million termination fee following the termination of their merger agreement. Concurrently, Lisata has reduced its workforce by approximately 72% to cut operating expenses and …

Lisata Therapeutics (LSTA) Pursues Legal Action After Merger Termination, Faces Valuation Challenges

Lisata Therapeutics (LSTA) has initiated legal proceedings against Kuva Labs and its subsidiary following the termination of their merger agreement, seeking a $2 million termination fee and damages for shareholders. Concurrently, Lisata is exploring strategic alternatives, including potential sales or liquidation, and has significantly …